<unk>  (YM150) is a direct inhibitor of factor Xa created by Astellas Pharma. It is an experimental drug that acts as an anticoagulant and antithrombotic to prevent venous thromboembolism after a major orthopaedic surgery, stroke in patients with atrial fibrillation and possibly ischemic events in acute coronary syndrome. It is used in form of the maleate. The development of<unk>  was discontinued in September 2011.
Darexaban
Enoxaparin
Edoxaban
Betrixaban
Oxeladin
Iotalamic acid
Apixaban
Heparin